JPRN-UMIN000002861招募中2 期
A phase II study of erlotinib for patients with pretreated non-small cell lung cancer with brain metastasis and sensitive EGFR mutations. - A phase II study of erlotinib for patients with pretreated non-small cell lung cancer with brain metastasis and sensitive EGFR mutations.
Shizuoka General Hospital Respiratory center0 个研究点目标入组 24 人开始时间: 2009年12月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with at least one of the following conditions are ineligible 1) Patients with idiopathic pulmonary fibrosis, other interstitial pneumonia, pneumoconiosis, active radiation pneumonitis, drug induced pulmonary damage 2)Patients with pleural effusion, ascites and/or pericardial effusion requiring drainage 3)Patients with infection requiring iv administration of antibiotics and/or antifungal agents 4)Patients who has received HER modulator medicine in the past 5)Patients unable to be treated with PO drugs 6) Clinically significant eye diseases such as severe dry eye, keratoconjunctivitis 7)Pregnant or breast feeding 8) Active synchronous malignancies 9) Uncontrolled diabetes mellitus 10)Other clinically significant complications 11)Patients judged as being in inappropriate condition for this study by physician
研究者
相似试验
已完成
2 期
A phase II study of Erlotinib for patients previously treated non-small cell lung cancer with epidermal growth factor receptor mutationon-small cell lung cancerJPRN-UMIN000004563Fukushima Medical University, cancer center26
已完成
2 期
Phase II study of Erlotinib for previously treated advanced or recurrent non-small-cell lung cancer with EGFR wild type and KRAS wild typeadvanced or recurrent non-small-cell lung cancerJPRN-UMIN000008398Gunma Uninersity Hospital30
已完成
不适用
PhaseII study of erlotinib in previously treated non-small cell lung cancer (NSCLC) with wild type EGFRPre-treated non-small cell lung cancer with wild type EGFR and occurred in never or light smokerJPRN-UMIN000005491Hiroshima citizens hospital Department of Medical Oncology40
已完成
2 期
Phase II study of erlotinib in previously treated non-small cell lung cancer (NSCLC) with wild type EGFR(NEJ006/TCOG0903)Pre-treated non-small cell lung cancer with wild type EGFR and occurred in never or light smokerJPRN-UMIN000002795orth East Japan Study Group /The Tokyo Cooperative Oncology Group43
已完成
2 期
A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutatioon-small cell lung cancerJPRN-UMIN000002716Central Japan Lung Study Group (CJLSG)29